Table 2. Changes in lipid profile and glycemia and satisfaction.
| ETR group | P value* | Control group | P value* | |||||
| Baseline (n = 22) | Week 24(n = 20 ) | Week 48(n = 20) | Baseline(n = 21) | Week 24(n = 20 ) | Week 48(n = 20) | |||
| Total cholesterol (mg/dL) | 207.2 (42.8) | 186 (41) | 190.8 (39.8) | <0.001 | 197.8 (47.4) | 204.4 (42.9 | 199 (49.6) | 0.71 |
| HDL-cholesterol (mg/dL) | 52.9 (18.3) | 48 (14.5) | 52.8 (20.4) | 0.88 | 54.2 (19.6) | 52.3 (21) | 55.1 (24.9) | 0.59 |
| CT/HDL-cholesterol ratio | 3.96 | 3.85 | 3.57 | 0.12 | 3.86 | 4.19 | 3.78 | 0.82 |
| LDL-cholesterol (mg/dL) | 116.6 (38.9) | 113 (33) | 110.5 (32.2) | 0.10 | 114.6 (43.8) | 121 (38.3) | 113.6 (35.4) | 0.50 |
| Triglycerides (mg/dL) | 186.4 (95.8) | 119.4 (56) | 132.4 (79.3) | <0.001 | 145.7 (106.4) | 157 (9) | 116.1 (58.5) | 0.14 |
| Glycemia (mg/dL) | 97.4 (11.3) | 94 (15) | 92.7 (11.7) | 0.03 | 90.3 (10.4) | 88 (7.4) | 88.0 (8.3) | 0.22 |
| Satisfaction ** | 7.7 (1.4) | 8.9 (1.3) | 9.2 (1.4) | <0.01 | 6 (2.3) | 5.6 (2.4) | 5.3 (2.1) | 0.21 |
All values are shown as mean (SD).
*
P values express intra-group differences between baseline and week 48.
Between groups, the only differences recorded were for triglycerides (p = 0.04) and glycemia (p = 0.03) at week 24.
HDL, High density lipoprotein; LDL, Low density lipoprotein.
**
Patient satisfaction was assessed using two 0–10 likert scales.